आईएसएसएन: 2168-9784
Panagiotis Papanastasopoulos
Cancer drug development is a lengthy and expensive process. Effective and non-invasive biomarkers are required to expedite the process of drug development. Functional imaging appears to have a rapidly emerging role, which is being discussed in this mini-review.